<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><description>姓药的来说药，带你进入最深层次的医药领域，把握医药动态，了解最新前沿！</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 07 Mar 2021 08:09:27 +0800</pubDate><image><url>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</url><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>小药谈双抗：挑战与开发策略</title><link>https://mp.weixin.qq.com/s/N0bYFNKxX57JNGwEzG57gg</link><description></description><content:encoded><![CDATA[小药谈双抗：挑战与开发策略]]></content:encoded><pubDate>Sun, 07 Mar 2021 06:14:09 +0800</pubDate></item><item><title>小药谈双抗：结构与功能优化</title><link>https://mp.weixin.qq.com/s/chE784-qcvyZzsnjUr3g6Q</link><description></description><content:encoded><![CDATA[小药谈双抗：结构与功能优化]]></content:encoded><pubDate>Sun, 07 Mar 2021 06:14:09 +0800</pubDate></item><item><title>小药谈双抗：BiTEs和它的兄弟姐妹</title><link>https://mp.weixin.qq.com/s/bGRa-ueVuVZWoFBkbPMAAQ</link><description></description><content:encoded><![CDATA[小药谈双抗：BiTEs和它的兄弟姐妹]]></content:encoded><pubDate>Sun, 07 Mar 2021 06:14:09 +0800</pubDate></item><item><title>小药谈双抗：CD33靶向双抗</title><link>https://mp.weixin.qq.com/s/CRvviuBQRs1T69sXzyeLjg</link><description></description><content:encoded><![CDATA[小药谈双抗：CD33靶向双抗]]></content:encoded><pubDate>Sun, 07 Mar 2021 06:14:09 +0800</pubDate></item><item><title>小药谈双抗: 阿斯利康PD-1/CTLA-4双抗</title><link>https://mp.weixin.qq.com/s/Wl7gZ6NaOH0CsX7C1lldUg</link><description></description><content:encoded><![CDATA[小药谈双抗: 阿斯利康PD-1/CTLA-4双抗]]></content:encoded><pubDate>Sun, 07 Mar 2021 06:14:09 +0800</pubDate></item><item><title>小药谈TME：Sialoglycans和Siglecs</title><link>https://mp.weixin.qq.com/s/PQbzn6zlldg4C2fOoi1e8Q</link><description></description><content:encoded><![CDATA[小药谈TME：Sialoglycans和Siglecs]]></content:encoded><pubDate>Sat, 06 Mar 2021 06:05:15 +0800</pubDate></item><item><title>小药谈TME：TGF-β</title><link>https://mp.weixin.qq.com/s/YJbCspyPmv5CmUzBpwPzVA</link><description></description><content:encoded><![CDATA[小药谈TME：TGF-β]]></content:encoded><pubDate>Sat, 06 Mar 2021 06:05:15 +0800</pubDate></item><item><title>小药谈TME：EZH2</title><link>https://mp.weixin.qq.com/s/0WC6Jq11D3g4Pq93NXaPUQ</link><description></description><content:encoded><![CDATA[小药谈TME：EZH2]]></content:encoded><pubDate>Sat, 06 Mar 2021 06:05:15 +0800</pubDate></item><item><title>小药谈TME：Treg</title><link>https://mp.weixin.qq.com/s/N_AW3zqcFS6zarhv1NSH6A</link><description></description><content:encoded><![CDATA[小药谈TME：Treg]]></content:encoded><pubDate>Sat, 06 Mar 2021 06:05:15 +0800</pubDate></item><item><title>小药谈TME：B细胞</title><link>https://mp.weixin.qq.com/s/wNmf1Eq-R5CCcxzrBaYE-A</link><description></description><content:encoded><![CDATA[小药谈TME：B细胞]]></content:encoded><pubDate>Sat, 06 Mar 2021 06:05:15 +0800</pubDate></item><item><title>小药谈TME：骨髓来源抑制细胞</title><link>https://mp.weixin.qq.com/s/oWGPQuYGBbb6bjy7Yh6dDw</link><description></description><content:encoded><![CDATA[小药谈TME：骨髓来源抑制细胞]]></content:encoded><pubDate>Sat, 06 Mar 2021 06:05:15 +0800</pubDate></item><item><title>小药谈TME：内质网应激信号</title><link>https://mp.weixin.qq.com/s/gTY-ZoKlG9nL7q2toBncIg</link><description></description><content:encoded><![CDATA[小药谈TME：内质网应激信号]]></content:encoded><pubDate>Sat, 06 Mar 2021 06:05:15 +0800</pubDate></item><item><title>小药谈NK细胞：肿瘤免疫中的NK细胞</title><link>https://mp.weixin.qq.com/s/5wTMbT7zAYsSkdvrCHZE2Q</link><description></description><content:encoded><![CDATA[小药谈NK细胞：肿瘤免疫中的NK细胞]]></content:encoded><pubDate>Fri, 05 Mar 2021 06:18:59 +0800</pubDate></item><item><title>小药谈NK细胞：NK细胞的免疫检查点</title><link>https://mp.weixin.qq.com/s/G386p2TBrmXpOMTXzucJcQ</link><description></description><content:encoded><![CDATA[小药谈NK细胞：NK细胞的免疫检查点]]></content:encoded><pubDate>Fri, 05 Mar 2021 06:18:59 +0800</pubDate></item><item><title>小药谈NK细胞：CAR-NK</title><link>https://mp.weixin.qq.com/s/-bj_j96PzzTYzNT3Di8GKw</link><description></description><content:encoded><![CDATA[小药谈NK细胞：CAR-NK]]></content:encoded><pubDate>Fri, 05 Mar 2021 06:18:59 +0800</pubDate></item><item><title>小药谈NK细胞：“变节”的NK细胞</title><link>https://mp.weixin.qq.com/s/yZ5Gi5ZiPcvEOEGbhljsAQ</link><description></description><content:encoded><![CDATA[小药谈NK细胞：“变节”的NK细胞]]></content:encoded><pubDate>Fri, 05 Mar 2021 06:18:59 +0800</pubDate></item><item><title>小药谈CAR-T：CAR-T的中国力量</title><link>https://mp.weixin.qq.com/s/SGEh7huMgujBaKmMLm6Ubw</link><description></description><content:encoded><![CDATA[小药谈CAR-T：CAR-T的中国力量]]></content:encoded><pubDate>Thu, 04 Mar 2021 06:15:52 +0800</pubDate></item><item><title>小药谈CAR-T：CAR-T的新靶点和新技术</title><link>https://mp.weixin.qq.com/s/JES5suT6dD8e4Y_dow8CyA</link><description></description><content:encoded><![CDATA[小药谈CAR-T：CAR-T的新靶点和新技术]]></content:encoded><pubDate>Thu, 04 Mar 2021 06:15:52 +0800</pubDate></item><item><title>小药谈CAR-T：针对实体瘤的挑战与开发策略</title><link>https://mp.weixin.qq.com/s/AW3E3w6eQyPFEJ7weV4xaw</link><description></description><content:encoded><![CDATA[小药谈CAR-T：针对实体瘤的挑战与开发策略]]></content:encoded><pubDate>Thu, 04 Mar 2021 06:15:52 +0800</pubDate></item><item><title>小药谈CAR-T：CAR-T与多发性骨髓瘤</title><link>https://mp.weixin.qq.com/s/30ZfoFeHZuFCBZzqn7K-UA</link><description></description><content:encoded><![CDATA[小药谈CAR-T：CAR-T与多发性骨髓瘤]]></content:encoded><pubDate>Thu, 04 Mar 2021 06:15:52 +0800</pubDate></item></channel></rss>